Both in Pharmaceuticals
Perspective Therapeutics vs Milestone Pharmaceuticals
Over the past year CATX returned −62.7% and MIST returned −58.0%; their daily moves had a correlation of 0.24.
CATX −62.7% MIST −58.0%Growth of $1, one year, split-adjusted
| Metric | CATX | MIST |
|---|---|---|
| Price | $0.8702 | $0.7725 |
| Market cap | $99.3M | $96.2M |
| Today | −1.11% | +1.74% |
| 1 month | −63.1% | +1.1% |
| 6 months | −77.2% | −60.8% |
| Year to date | −68.4% | −61.8% |
| 1 year | −66.5% | −58.2% |
| Revenue growth (YoY) | −72.1% | — |
| Gross margin | 100.0% | 94.3% |
| Net margin | −33069.1% | −5118.8% |
| P/E (TTM) | — | — |
| Price / sales | 242.9× | 41.0× |
| Net cash | $235.3M | $111.4M |
| Dividend yield | — | — |
| Volatility (60d) | 117.1% | 74.2% |
| Short % of float | 17.1% | 17.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).